English | Spanish
ecancer
Supporting oncology professionals through education
Login Register

The content on this site is intended for healthcare professionals only

  • Home
  • News
  • Journal
  • Video
  • elearning
  • Events
  • Conferences
  • About us
Breast Prostate & urology Lung & pleura Colorectal & gastro Melanoma & skin Head & neck Ovary & gynaecology Bone Brain & nervous system Haematology oncology Hepatobiliary pancreatic Paediatric Neuroendocrine Sarcomas

News

  • Latest news
  • Sign up for news alerts
  • Submit your news

Explore

  • Bone
  • Brain & nervous system
  • Breast
  • Colorectal & gastro
  • Haematology oncology
  • Head & neck
  • Hepatobiliary pancreatic
  • Lung & pleura
  • Melanoma & skin
  • Neuroendocrine
  • Ovary & gynaecology
  • Paediatric
  • Prostate & urology
  • Sarcomas

Journal information

  • Journal home
  • Charges
  • Editorial board
  • Founding editors
  • Editor-in-chief
  • Contact us

Author information

  • Submit article
  • Author guidelines
  • Editorial policies
  • Copyright information
  • Why publish with us

Reviewer information

  • Reviewer guidelines

Memberships

Open Access Scholarly Publishers Association Crossref Healthcare Information For All Commitee On Publication Ethics

Videos

  • Recent videos
  • Sign up

Explore

  • Bone
  • Brain & nervous system
  • Breast
  • Colorectal & gastro
  • Haematology oncology
  • Head & neck
  • Hepatobiliary pancreatic
  • Lung & pleura
  • Melanoma & skin
  • Neuroendocrine
  • Ovary & gynaecology
  • Paediatric
  • Prostate & urology
  • Sarcomas

Conferences

  • Latest conferences
  • Sign up for latest coverage
  • Submit your event

About ecancer

  • About ecancer
  • Our founders
  • Funding statement
  • Contact us
  • Home
  • News
  • Journal
  • Video
  • elearning
  • Events
  • Conferences
  • About us
Breast Prostate & urology Lung & pleura Colorectal & gastro Melanoma & skin Head & neck Ovary & gynaecology
+ -
Bone Brain & nervous system Haematology oncology Hepatobiliary pancreatic Paediatric Neuroendocrine Sarcomas

ecancer and the City Cancer Challenge have formed an educational collaboration. Learners who are part of the City Cancer Challenge's project can access additional education provided by them.

Please login or register. Then you can use this button to confirm you are part of this project.
Register for free Already have an account? Login
Videos [2699]
News [7552]
Articles [308]
Editorials [8]
Conferences [228]
elearning [48]
Part 1: Why test?
Dr Elena Castro - Hospital Universitario 12 de Octubre, Madrid, Spain
Part 1: Why test? ( Dr Elena Castro - Hospital Universitario 12 de Octubre, Madrid, Spain )
5 May 2026
Part 2: How to get biopsies for testing?
Dr Lynda Corrigan and Dr Stephen Finn
Part 2: How to get biopsies for testing? ( Dr Lynda Corrigan and Dr Stephen Finn )
5 May 2026
Part 3: Managing testing efficiencies – How to optimise next generation...
Prof Eva Compérat - Medical University of Vienna, Vienna, Austria
Part 3: Managing testing efficiencies – How to optimise next generation sequencing and HRR testing ( Prof Eva Compérat - Medical University of Vienna, Vienna, Austria )
5 May 2026
ctDNA predicts early treatment response in HPV-associated anal cancer
Dr Phebe Mawuena Afi Havor - Moffitt Cancer Center, Tampa, USA
ctDNA predicts early treatment response in HPV-associated anal cancer ( Dr Phebe Mawuena Afi Havor - Moffitt Cancer Center, Tampa, USA )
23 Apr 2026
mCRPC treatment sequencing: Need for optimal therapy at the earliest opportunity
Prof Rana McKay - University of California San Diego, San Diego, USA
mCRPC treatment sequencing: Need for optimal therapy at the earliest opportunity ( Prof Rana McKay - University of California San Diego, San Diego, USA )
23 Apr 2026
Low-dose CT screening reduces lung cancer mortality and improves survival in...
Dr Caichen Li - Guangzhou Medical University, Guangzhou, China
Low-dose CT screening reduces lung cancer mortality and improves survival in broad populations ( Dr Caichen Li  - Guangzhou Medical University, Guangzhou, China )
13 Apr 2026
EAU 2026: Updates in NMIBC
Dr Francesco Soria, Prof Jonathan Aning, Dr Antoni Vilaseca and Prof Alexandra...
EAU 2026: Updates in NMIBC ( Dr Francesco Soria, Prof Jonathan Aning, Dr Antoni Vilaseca and Prof Alexandra Masson-Lecomte )
18 Mar 2026
First real-world study of penile cancer in Bolivia reveals high HPV-related...
Dr Lucia Richter - Instituto Oncologico del Oriente Boliviano, Santa Cruz De La...
First real-world study of penile cancer in Bolivia reveals high HPV-related rates and advanced disease ( Dr Lucia Richter - Instituto Oncologico del Oriente Boliviano, Santa Cruz De La Sierra, Bolivia )
18 Mar 2026
ASCO GU 2026: Updates in metastatic prostate cancer
Dr María Natalia Gandur Quiroga - Instituto de Oncología 'Ángel H. Roffo'...
ASCO GU 2026: Updates in metastatic prostate cancer ( Dr María Natalia Gandur Quiroga - Instituto de Oncología 'Ángel H. Roffo', Universidad de Buenos Aires, Argentina )
17 Mar 2026
Understanding breast cancer care systems with the BCCi
Dr Benjamin Anderson - University of Washington, Seattle, USA
Understanding breast cancer care systems with the BCCi ( Dr Benjamin Anderson - University of Washington, Seattle, USA )
30 Jan 2026
Resource disparities in cancer treatment in Mexico
Dr Elysse Bautista-Gonzalez - La Fundación Mexicana para la Salud, Mexico City...
Resource disparities in cancer treatment in Mexico ( Dr Elysse Bautista-Gonzalez - La Fundación Mexicana para la Salud, Mexico City, Mexico )
23 Jan 2026
Tepotinib in second line NSCLC treatment
Dr Antonio Passaro and Prof Raffaele Califano
Tepotinib in second line NSCLC treatment ( Dr Antonio Passaro and Prof Raffaele Califano )
20 Jan 2026
<12345…225>

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation

  • Contact
  • Projects
  • Cookie Policy
  • Terms of Use
  • Desktop Site
  • Privacy Policy
© 2026 ecancer, all rights reserved
UK registered charity number: 1176307
Back to Top